| 749758 |
FRONTIERS IN ONCOLOGY |
Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway |
2021-10-01 |
10.3389/fonc.2021.722754 |
Tsai Hong-Chieh, Wei Kuo-Chen, Chen Pin-Yuan, Huang Chiung-Yin, Chen Ko-Ting, Lin Ya-Jui, Cheng Hsiao-Wei, Chen Yi-Rou, Wang Hsiang-Tsui |
| 749757 |
FRONTIERS IN ONCOLOGY |
The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias |
2021-10-01 |
10.3389/fonc.2021.741376 |
Jasiński Marcin, Biliński Jarosław, Basak Grzegorz W. |
| 749756 |
FRONTIERS IN ONCOLOGY |
CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells |
2021-10-01 |
10.3389/fonc.2021.743050 |
Chen Ruo, Huang Min, Yang Xu, Chen Xiao-Hong, Shi Ming-Yan, Li Zhuo-Fan, Chen Zhi-Nan, Wang Ke |
| 749755 |
FRONTIERS IN ONCOLOGY |
Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients |
2021-10-01 |
10.3389/fonc.2021.740336 |
Assi Hazem I., Alameh Ibrahim A., Khoury Jessica, Bou Zerdan Maroun, Akiki Vanessa, Charafeddine Maya, El Saheb Ghida I., Sukhon Fares, Sbaity Eman, Baydoun Serine, Shabb Nina, Berjawi Ghina, Haidar Mohamad B. |
| 749754 |
FRONTIERS IN ONCOLOGY |
Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma |
2021-10-01 |
10.3389/fonc.2021.755814 |
Yu Zhenjun, Zhang Yu, Shao Shuai, Liu Qi, Li Yuhan, Du Xiaoxiao, Zhang Kun, Zhang Mengxia, Yuan Haixia, Yuan Qiang, Liu Tong, Gao Yingtang, Wang Yijun, Hong Wei, Han Tao |
| 749753 |
FRONTIERS IN ONCOLOGY |
Do We Need Intraoperative Magnetic Resonance Imaging in All Endoscopic Endonasal Pituitary Adenoma Surgery Cases? A Retrospective Study |
2021-10-01 |
10.3389/fonc.2021.733838 |
Celtikci Emrah, Sahin Muammer Melih, Sahin Mustafa Caglar, Cindil Emetullah, Demirtaş Zuhal, Emmez Hakan |
| 749752 |
FRONTIERS IN ONCOLOGY |
Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer |
2021-10-01 |
10.3389/fonc.2021.754975 |
Yang Ming, Tan Lingling, Xie Lingling, Hu Song, Liu Dan, Wang Jing, Li Weimin |
| 749751 |
FRONTIERS IN ONCOLOGY |
Use of Machine Learning and Statistical Algorithms to Predict Hospital Length of Stay Following Colorectal Cancer Resection: A South African Pilot Study |
2021-10-01 |
10.3389/fonc.2021.644045 |
Achilonu Okechinyere J., Fabian June, Bebington Brendan, Singh Elvira, Nimako Gideon, Eijkemans Rene M. J. C., Musenge Eustasius |
| 749750 |
FRONTIERS IN ONCOLOGY |
The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer |
2021-10-01 |
10.3389/fonc.2021.706910 |
Wei Jiayan, Feng Jia, Weng Yiming, Xu Zexi, Jin Yao, Wang Peiwei, Cui Xue, Ruan Peng, Luo Ruijun, Li Na, Peng Min |
| 749749 |
FRONTIERS IN ONCOLOGY |
A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance |
2021-10-01 |
10.3389/fonc.2021.722039 |
Liu Li, Qu Jingjing, Heng Jianfu, Zhou Chunhua, Xiong Yi, Yang Haiyan, Jiang Wenjuan, Zeng Liang, Zhu Songlin, Zhang Yongchang, Tan Jiarong, Hu Chengping, Deng Pengbo, Yang Nong |
